Evidence map›Paper›PMID 35327564›Full record

ArticleBiomolecules2022

VEGFA, B, C: Implications of the C-Terminal Sequence Variations for the Interaction with Neuropilins.

Charles Eldrid, Mire Zloh, Constantina Fotinou, Tamas Yelland, Lefan Yu, Filipa Mota, David L Selwood, Snezana Djordjevic

Open access · goldAbstract read
In one paragraph

Article in Biomolecules, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Charles EldridStructural and Molecular Biology, ISMB, Division of Biosciences, University College London, Gower Street, London WC1E 6BT, UK.
Mire ZlohUCL School of Pharmacy, University College London, London WC1N 1AX, UK.ORCID 0000-0002-4848-2737
Constantina FotinouStructural and Molecular Biology, ISMB, Division of Biosciences, University College London, Gower Street, London WC1E 6BT, UK.
Tamas YellandStructural and Molecular Biology, ISMB, Division of Biosciences, University College London, Gower Street, London WC1E 6BT, UK.
Lefan YuStructural and Molecular Biology, ISMB, Division of Biosciences, University College London, Gower Street, London WC1E 6BT, UK.
Filipa MotaWolfson Institute for Biomedical Research, University College London, Gower Street, London WC1E 6BT, UK.
David L SelwoodWolfson Institute for Biomedical Research, University College London, Gower Street, London WC1E 6BT, UK.ORCID 0000-0002-6817-5064
Snezana DjordjevicStructural and Molecular Biology, ISMB, Division of Biosciences, University College London, Gower Street, London WC1E 6BT, UK.
Institute of Structural and Molecular Biology · GBUniversity College London · GBUniversity of Novi Sad · RS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vascular endothelial growth factors (VEGFs) are the key regulators of blood and lymphatic vessels' formation and function. Each of the proteins from the homologous family VEGFA, VEGFB, VEGFC and VEGFD employs a core cysteine-knot structural domain for the specific interaction with one or more of the cognate tyrosine kinase receptors. Additional diversity is exhibited by the involvement of neuropilins-transmembrane co-receptors, whose b1 domain contains the binding site for the C-terminal sequence of VEGFs. Although all relevant isoforms of VEGFs that interact with neuropilins contain the required C-terminal Arg residue, there is selectivity of neuropilins and VEGF receptors for the VEGF proteins, which is reflected in the physiological roles that they mediate. To decipher the contribution made by the C-terminal sequences of the individual VEGF proteins to that functional differentiation, we determined structures of molecular complexes of neuropilins and VEGF-derived peptides and examined binding interactions for all neuropilin-VEGF pairs experimentally and computationally. While X-ray crystal structures and ligand-binding experiments highlighted similarities between the ligands, the molecular dynamics simulations uncovered conformational preferences of VEGF-derived peptides beyond the C-terminal arginine that contribute to the ligand selectivity of neuropilins. The implications for the design of the selective antagonists of neuropilins' functions are discussed.

Indexed as

NeuropilinsVascular Endothelial Growth Factor ALigandsPeptidesVascular Endothelial Growth FactorsLigandsNeuropilinsPeptidesVascular Endothelial Growth Factor AVascular Endothelial Growth Factorsligand-binding proteinmolecular dynamicsneuropilinSPRX-ray crystallography

Identifiers

PMID35327564
PMCPMC8945599
OpenAlexW4214649166

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.